Dr. Dino PratoEnvita Medical Centers · Founder and CEO at Envita Medical Centers

Conventional oncology treats the disease precision medicine treats the person #shorts

30 Jan 2026 · 1 min

Watch on YouTube

0:31

In this YouTube short, the speaker argues that conventional oncology follows a one‑size‑fits‑all approach, relying on double‑blind placebo clinical trials and NCCN (National Comprehensive Cancer Network) guidelines that treat patients with the same cancer type and stage identically. He contends that this mass‑treatment model is designed for the average patient, but real-world data show that each cancer is biologically unique. By ignoring this uniqueness, conventional oncology has missed the opportunity to adopt precision, person‑centered medicine that tailors treatment to the individual tumor’s characteristics.

Chapters

Conventional oncology. It's a one size fits all model. It's based on the double blind placebo clinical trials. That means that people with the same type and stage of cancer are all treated the same. So we can take a breast cancer, same type and stage, colon, same type, prostate, pancreatic, whatever, and they're given the same treatment based on the National Comprehensive Cancer Network guidelines. The problem is this is designed for the masses, but when you actually run more data, they're all unique. Each cancer is unique. And this is where they missed a boat.